Nine Ten Capital Management 13F annual report

Nine Ten Capital Management is an investment fund managing more than $260 billion ran by Michelle Katauskas. There are currently 10 companies in Mrs. Katauskas’s portfolio. The largest investments include Cellebrite Di Ltd and Iradimed Corp, together worth $85.5 billion.

$260 billion Assets Under Management (AUM)

As of 7th August 2024, Nine Ten Capital Management’s top holding is 3,923,712 shares of Cellebrite Di Ltd currently worth over $46.9 billion and making up 18.0% of the portfolio value. In addition, the fund holds 877,802 shares of Iradimed Corp worth $38.6 billion, whose value fell 3.9% in the past six months. The third-largest holding is Stonex Group Inc worth $33.3 billion and the next is Agilysys, Inc worth $27.4 billion, with 263,460 shares owned.

Currently, Nine Ten Capital Management's portfolio is worth at least $260 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Nine Ten Capital Management

The Nine Ten Capital Management office and employees reside in Chicago, Illinois. According to the last 13-F report filed with the SEC, Michelle Katauskas serves as the CCO/COO at Nine Ten Capital Management.

Recent trades

In the most recent 13F filing, Nine Ten Capital Management revealed that it had increased its stake in Cellebrite Di Ltd and bought 452,514 additional shares worth around .

On the other hand, there are companies that Nine Ten Capital Management is getting rid of from its portfolio. Nine Ten Capital Management closed its position in Olo Inc on 14th August 2024. It sold the previously owned 1,861,663 shares for $10.2 billion. Michelle Katauskas also disclosed a decreased stake in Stonex Group Inc by 0.4%. This leaves the value of the investment at $33.3 billion and 442,491 shares.

One of the smaller hedge funds

The two most similar investment funds to Nine Ten Capital Management are Caden Capital Partners, L.P. and Bill Few Associates. They manage $260 billion and $260 billion respectively.

Michelle Katauskas investment strategy

Nine Ten Capital Management’s portfolio is diversified across 5 sectors. Currently, their heaviest sector is Consumer Discretionary — making up 20.7% of the total portfolio value. The fund focuses on investments in the United States as 70.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $1.24 billion.

The complete list of Nine Ten Capital Management trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Cellebrite Di Ltd	13.04% 3,923,712	$46,888,000,000	18.05%
Iradimed Corp	8.46% 877,802	$38,571,000,000	14.85%
Stonex Group Inc	40.57% 442,491	$33,324,000,000	12.83%
Agilysys, Inc	47.04% 263,460	$27,437,000,000	10.56%
Sapiens Intl Corp N V	344.68% 732,227	$24,844,000,000	9.56%
Winmark Corporation	8.22% 68,500	$24,155,000,000	9.30%
Magnite Inc	55.50% 1,652,793	$21,966,000,000	8.45%
Franklin Covey Co.	13.43% 433,166	$16,460,000,000	6.34%
NV5 Global Inc	18.05% 140,963	$13,105,000,000	5.04%
XPEL Inc	20.04% 367,416	$13,065,000,000	5.03%
Olo Inc	Closed 1,861,663	$10,221,000,000
SoundThinking Inc	Closed 641,932	$10,194,000,000
Cogent Communications Hldgs	Closed 93,612	$6,116,000,000
No transactions found
Showing first 500 out of 13 holdings